The Endogenous Dual Retinoid Receptor Agonist Alitretinoin Exhibits Immunoregulatory Functions on Antigen-Presenting Cells.
9-cis RA
RAR
RXR
alitretinoin
chronic hand eczema
dendritic cells
human primary keratinocytes
retinoids
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
02 Jun 2023
02 Jun 2023
Historique:
received:
01
04
2023
revised:
20
05
2023
accepted:
25
05
2023
medline:
12
6
2023
pubmed:
10
6
2023
entrez:
10
6
2023
Statut:
epublish
Résumé
Retinoids are a frequently used class of drugs in the treatment of inflammatory as well as malignant skin diseases. Retinoids have differential affinity for the retinoic acid receptor (RAR) and/or the retinoid X receptor (RXR). The endogenous dual RAR and RXR agonist alitretinoin (9-
Identifiants
pubmed: 37298605
pii: ijms24119654
doi: 10.3390/ijms24119654
pmc: PMC10253969
pii:
doi:
Substances chimiques
Alitretinoin
1UA8E65KDZ
Retinoids
0
Tretinoin
5688UTC01R
Receptors, Retinoic Acid
0
Retinoid X Receptors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Arch Dermatol Res. 2013 Dec;305(10):857-66
pubmed: 24085571
J Dermatolog Treat. 2017 Dec;28(8):684-696
pubmed: 28318351
Cell Death Differ. 2007 Jul;14(7):1315-23
pubmed: 17396131
J Invest Dermatol. 2019 Sep;139(9):1867-1875.e7
pubmed: 30905808
J Invest Dermatol. 2014 Jul;134(7):1941-1950
pubmed: 24518171
Semin Immunol. 2009 Feb;21(1):8-13
pubmed: 18849172
Immunol Invest. 2009;38(6):498-509
pubmed: 19811408
J Leukoc Biol. 2000 Oct;68(4):568-74
pubmed: 11037980
Semin Oncol. 2016 Feb;43(1):49-64
pubmed: 26970124
Semin Immunol. 2009 Feb;21(1):1
pubmed: 18838279
Leuk Res. 2010 Apr;34(4):513-20
pubmed: 19883939
Biomedicines. 2021 Feb 26;9(3):
pubmed: 33652835
Nat Commun. 2019 Oct 16;10(1):4703
pubmed: 31619666
BMC Cancer. 2014 Dec 02;14:898
pubmed: 25465225
J Clin Invest. 2003 Aug;112(3):332-44
pubmed: 12897202
J Biol Chem. 1997 Jun 6;272(23):15036-42
pubmed: 9169480
Am Rev Respir Dis. 1993 Jul;148(1):91-7
pubmed: 8317821
Cell Immunol. 2009;259(1):41-8
pubmed: 19540457
Ther Clin Risk Manag. 2020 Dec 31;16:1319-1332
pubmed: 33408476
J Drugs Dermatol. 2014 Oct;13(10):1198-204
pubmed: 25607554
Genome Biol. 2014;15(12):550
pubmed: 25516281
Front Immunol. 2015 Oct 19;6:528
pubmed: 26539195
J Immunol. 2007 Apr 1;178(7):4240-9
pubmed: 17371980
J Invest Dermatol. 2008 Apr;128(4):797-807
pubmed: 17943186
Physiol Rev. 2012 Apr;92(2):739-89
pubmed: 22535896
Expert Opin Investig Drugs. 2022 Aug;31(8):843-853
pubmed: 35658708
Blood. 1997 Aug 15;90(4):1600-10
pubmed: 9269779
J Immunol. 2005 Oct 1;175(7):4383-91
pubmed: 16177079
Oncogene. 2001 May 28;20(24):3047-54
pubmed: 11420720
Eur J Dermatol. 2015 Sep-Oct;25(5):384-91
pubmed: 26069148
J Immunol. 2011 Jun 15;186(12):7144-55
pubmed: 21593381
Cells. 2020 Dec 11;9(12):
pubmed: 33322246
J Immunol. 1995 Jan 1;154(1):97-105
pubmed: 7527824
Br J Dermatol. 2015 Apr;172(4):994-1001
pubmed: 25244099
Stem Cells. 2016 Mar;34(3):781-90
pubmed: 26731338
Zhonghua Er Ke Za Zhi. 2004 May;42(5):340-3
pubmed: 15189689
Immunity. 2011 Jul 22;35(1):13-22
pubmed: 21777796
J Biol Chem. 1997 Oct 10;272(41):25881-9
pubmed: 9325320
Pharmaceuticals (Basel). 2021 Sep 24;14(10):
pubmed: 34681186
Curr Opin Investig Drugs. 2010 Nov;11(11):1211-20
pubmed: 21157640
Mini Rev Med Chem. 2005 Aug;5(8):755-60
pubmed: 16101411
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7135-40
pubmed: 12782789
Mucosal Immunol. 2015 Jul;8(4):773-84
pubmed: 25389034